About the DAYBREAK-ALZ Study
The study will examine an oral investigational drug that may have some effect on the brain changes associated with Alzheimer’s disease. The study is designed to find out whether this investigational drug (or “study drug”) can slow down the decline in memory and mental functioning.
The DAYBREAK-ALZ study will include approximately 1,900 participants from around the globe.
There is no cost to participate. Volunteers who take part in the study will receive all study-related care, from a Specialist Physician, at no cost.
You may be compensated up to $150 per visit for your time and travel expenses.
Who can join the DAYBREAK-ALZ Study?
To join the study you must:
Be between 55 and 85 years old
Have a close friend, relative or partner who would be willing to be your study partner throughout the study
Have experienced a gradual loss of memory over the last 6 months (the study team will assess whether this is due to Alzheimer’s disease) or have been diagnosed with mild Alzheimer’s disease
If you think you might like to join the DAYBREAK-ALZ study or you would like to learn more, please contact us. We can tell you more about it and explain what participating would mean for you. We will talk through the potential benefits and risks of being involved in the study, before you make your decision about joining.
We will also carry out several medical checks to see whether you are right for the study, and the study is right for you.